Journal of Chemistry

New visible spectrophotometric methods for estimation of ziprasidone in pharmaceutical formulations

Author & Affiliation:
A. SREELAKSHMI
Department of Biotechnology, Montessori Mahila Kalasala, VIJAYAWADA-520 010 Andhra Pradesh (INDIA)
G SUDHAKARASAI BABU
K.V.S. R. Siddhartha College of Pharmaceutical Sciences, VIJAYAWADA-520 010 Andhra Pradesh (INDIA)
G. DEVALA RAO
K.V.S. R. Siddhartha College of Pharmaceutical Sciences, VIJAYAWADA-520 010 Andhra Pradesh (INDIA)
Keyword:
Ziprasidone, Spectrophotometric
Issue Date:
December 2009
Abstract:

Ziprasidone is a typical antipsychotic agent. Two simple, sensitive and accurate spectrophotometric methods have been developed for the determination of Ziprasidone hydrochloride (ZPD) in pure state and in its pharmaceutical formulations. The developed Method A is based on the diazocoupling reaction of the Brotton-Marshall's reagent with drug and it shows maximum absorption at max 540 nm; Linearity in the range of 2-10 pg/mL. Method B is based on the reaction between drug and 1, 10-phenanthroline with ferric chloride and orthophosphoric acid to form a colored chromogen and it shows maximum absorption at A. ,nax 520 nm and Linearity in the range of 4-20 pg/mL. The results obtained were statistically evaluated and were found to be accurate and reproducible.

Pages:
422-426
ISSN:
2319-8036 (Online) - 0973-3450 (Print)
Source:
DOI:
juc

Copy the following to cite this article:

A. Sreelakshmi; G. S. Babu; G. D. Rao, "New visible spectrophotometric methods for estimation of ziprasidone in pharmaceutical formulations", Journal of Ultra Chemistry, Volume 5, Issue 3, Page Number 422-426, 2018

Copy the following to cite this URL:

A. Sreelakshmi; G. S. Babu; G. D. Rao, "New visible spectrophotometric methods for estimation of ziprasidone in pharmaceutical formulations", Journal of Ultra Chemistry, Volume 5, Issue 3, Page Number 422-426, 2018

Available from: http://journalofchemistry.org/paper/877/

Ansari Education And Research Society
Facebook Google Plus Twitter
Secured Site
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License Cross Ref ACS